{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T08:48:59Z","timestamp":1745052539186},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"DOI":"10.2146\/ajhp100258","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T23:45:39Z","timestamp":1297986339000},"page":"399-401","source":"Crossref","is-referenced-by-count":7,"title":["Olanzapine-induced parkinsonism associated with smoking cessation"],"prefix":"10.1093","volume":"68","author":[{"given":"Jennifer","family":"Arnoldi","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Repking","sequence":"additional","affiliation":[{"name":"Walgreens, Effingham, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041105534332800_b1-0680399","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.159.2.255","article-title":"Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder","volume":"259","author":"Volavka","year":"2002","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019041105534332800_b2-0680399","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00007691-200410000-00018","article-title":"Heavy smoking, reduced olanzapine levels, and treatment effects","volume":"26","author":"Chiu","year":"2004","journal-title":"Ther Drug Monit"},{"key":"key\n\t\t\t\t2019041105534332800_b3-0680399","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2146\/ajhp060414","article-title":"Drug interactions with smoking","volume":"64","author":"Kroon","year":"2007","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041105534332800_b4-0680399","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00007691-200302000-00007","article-title":"Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication","volume":"25","author":"Gex-Fabry","year":"2003","journal-title":"Ther Drug Monit"},{"key":"key\n\t\t\t\t2019041105534332800_b5-0680399","volume-title":"Zyprexa (olanzapine) package insert","year":"2009"},{"key":"key\n\t\t\t\t2019041105534332800_b6-0680399","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/pgmj.2008.073312","article-title":"Drug induced parkinsonism: a common cause of parkinsonism in older people","volume":"85","author":"Thanvi","year":"2009","journal-title":"Postgrad Med J"},{"key":"key\n\t\t\t\t2019041105534332800_b7-0680399","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.161.1.160","article-title":"Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients","volume":"161","author":"Janno","year":"2004","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019041105534332800_b8-0680399","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9343(99)80104-1","article-title":"Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study","volume":"99","author":"Avorn","year":"1995","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041105534332800_b9-0680399","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00002512-199405020-00006","article-title":"Drug-induced parkinsonism in the aged: recognition and prevention","volume":"5","author":"Gershanik","year":"1994","journal-title":"Drugs Aging"},{"key":"key\n\t\t\t\t2019041105534332800_b10-0680399","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004850-200205000-00008","article-title":"Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine","volume":"17","author":"Zullino","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"key\n\t\t\t\t2019041105534332800_b11-0680399","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041105534332800_b12-0680399","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1345\/aph.1H423","article-title":"Proposal for a new tool to evaluate drug interaction cases","volume":"41","author":"Horn","year":"2007","journal-title":"Ann Pharmacother"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/68\/5\/399\/28348978\/ajhp0399.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T12:44:05Z","timestamp":1559997845000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/68\/5\/399\/5129664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,3,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp100258","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,3,1]]},"published":{"date-parts":[[2011,3,1]]}}}